Literature DB >> 21218064

Synthesis and Antimicrobial Screening of Pyrazolo-3-Aryl Quinazolin-4(3H)ones.

M B Deshmukh1, S Patil, S S Patil, S D Jadhav.   

Abstract

2-thio-3-aryl quinazolin-4(3H)one (1) was synthesized by reacting anthranilic acid with thiocarbamate salts of substituted aniline and carbon disulphide, which on reflux with excess of hydrazine hydrate to form 2-hydrazino quinazolin-4(3H)one derivatives (2). The reaction of (2) with variously substituted aryl aldehydes gave the corresponding hydrazones (3). Further, the cyclization of compound (3) in acetic anhydride gave tricyclic pyrazoloquinazolinones (4). All newly synthesized compounds have been tested for their antibacterial activity against gram +ve bacteria B. substilis, S. aureus and gram -ve bacteria E. coli, P. vulgaris. The species used for antifungal activity are Aspergillus niger and Phytophora. Introduction of -OCH3, -OH and -Cl groups to the heterocyclic frame work enhanced antibacterial and antifungal activities.

Entities:  

Keywords:  Acetic anhydride; hydrazino; hydrazones; pyrazolo-quinazolinones; quinazolinones

Year:  2010        PMID: 21218064      PMCID: PMC3013576          DOI: 10.4103/0250-474X.73934

Source DB:  PubMed          Journal:  Indian J Pharm Sci        ISSN: 0250-474X            Impact factor:   0.975


Derivatives quinazolines are of special importance because of their versatile biological activities[12], especially antihistaminic[3], antiinflammatory[4], antihypertensive[5], antiHIV[6], antifungal[67], antimicrobial[89], anticonvulsant[10], antithrombotic[11], antitubercular[1213], antitumor[14], analgesic[15], antibacterial[615] and insecticidal[16]. In this paper, a new route for the synthesis of pyrazolo quinazolinones is reported. The strategy employed for the synthesis of desired compounds involved the sequential treatment of anthranilic acid with thiocarbamate salts of substituted aniline and carbon disulphide to give substituted 2-thio-3-aryl quinazol-4(3H)ones (1). The appearance of broad band at 3330-3110 cm-1 in IR spectrum and a singlet displayed at δ, 10-13 ppm in the PMR spectrum due to -SH supports their formation. Compound (1) were refluxed with excess hydrazine hydrate to form 2-hydrazino derivative (2), the formation witch has been explained by the appearance of IR band at 3390-3100 cm-1 due to -NHNH2 and disappearance of signal observed at δ, 10-13 ppm due to -SH and the appearance of two additional singlet between δ, 9-11 and δ, 2-7 ppm due to -NH and -NH2 protons, respectively in their PMR spectra. The condensation of (2) with variously substituted aryl aldehydes gave the corresponding hydrazones (3). The appearance -NH and =CH protons at δ, 5.1 and δ, 8.2 in PMR spectrum and also disappearance of -NH2 band 3390-3200 cm-1 in IR spectrum indicated their formation. Further, the cyclization of compound (3) in acetic anhydride gave tricyclic triazolo quinazolones (4). The formation of these compounds have been established by the disappearance of the PMR singlet due to -NH and =CH displayed at δ, 5.1 and δ, 8.2, respectively in the PMR spectrum of (3).(Scheme 1)
Scheme 1

Synthetic route for synthesis of Quinazolin-4(3H)One derivatives

Synthetic route for synthesis of Quinazolin-4(3H)One derivatives All chemicals used were of AR grade and are used without further purification. Melting points were determined by open capillary method and are uncorrected. 1H NMR spectra in DMSO-d6 were scanned on a Bruker A-300 F-NMR spectrometer. IR spectra were recorded on a Perkin-Elmer 783 (FTIR) spectrophotometer. Purity of the products in addition to the elemental analysis was checked by TLC. The starting compound (1) was prepared by reported method[17]. 2-Hydrazino 3-p-methoxy phenyl quinazolin-4(3H)one (2a) was synthesized as follows; The compound (la) (5.0 g, 0.018 mole) was refluxed with excess of hydrazine hydrate (15 ml) with constant stirring at 100°C for about 1 ½ h, cooled and the solid obtained was filtered and recrystallized from ethanol to furnish (2a), IR(KBr); 3386-3328 (-HNNH 2), 1664 (cyclic amido C=O) cm-1; 1H NMR (DMSO-d6): δ, 3.81(3H,s,Ar-OCH3), 6.25(2H,s,-NH2), 6.9-7.8(8H,m, Ar-H), 10.9(1H,s, br, -NH). 2-(p-Methoxybenzylidene)hydrazine-3-(p-methoxyphenyl)quinazolin-4-(3H)one (3a-1) was synthesized using following procedure; the mixture of compound (2a) (0.2 g, 0.0007 mole) and p-methoxy benzaldehyde (0.1 g, 0.0007 mole) in ethanol (10 ml) to which two drops of acetic acid were added and the reaction mixture heated on oil bath for 5 h. The separated solid was filtered under vacuum and further recrystallized from DMF, IR(KBr); 3100-3350(-NH), 1665 cm-1 (cyclic amido >C=O), 1600 cm-1(-C=N); 1H NMR (DMSO-d6): 3.82 (3H, s, Ar-OCH3), 3.84 (3H, s, another Ar-OCH3), 6.00 (1H, s, br, -NH), 8.21 (1H, s, =CH), 6.8-8.1 (12H, m, Ar-H), 8.20 (=CH) ppm. 3,5’-(p-Dimethoxyphenyl) pyrazolo-[3’,4’-a] quinazolin-4(3H)one (4a-1) was synthesized as follows; To a solution of compound (3a-1) (0.1 g, 0.00025 mole) in acetic anhydride (10 ml) was refluxed for about 2 h then poured in ice-cold water and separated solid was filtered, recrystallized from DMF to get desired tricyclic pyrazolo quinazolinones, IR (KBr): 1665 cm-1 (cyclic amido > C=O) and 1620 cm-1 (C=N); 1H NMR: (DMSO-d6): 3.79 (3H, s, Ar-OCH3) 3.95(3H, s, another Ar-OCH3), 6.8-8.2(12H, m, Ar-H) ppm. (Table 1)
TABLE 1

CHARACTERIZATION DATA OF COMPOUNDS 2, 3 AND 4

S. No.R GroupsM.P.(o)Yield (%)Mol. Formula% C
% H
% N
Cal.FoundCal.FoundCal.Found
2ap-OCH320576C15H14O2N463.8263.765.005.1019.8519.90
2bp-CH321586C15H14ON467.6567.595.305.3821.0421.10
2cp-Cl21882C14H11ON4Cl58.6558.583.874.9519.5419.47
2dp-Br19683C14H11ON4Br50.7850.623.353.4016.9216.86
R’groups
4a-1p-OCH3C6H423083C23H18O3N469.3469.454.554.4114.0613.86
4a-2o-NO2C6H419378C22H15O4N563.9263.853.663.7016.9416.82
4a-33,4,5(OCH3)3-C6H221168C25H22O5N465.4967.004.844.8912.2212.18
4a-4o-OHC6H421677C22H16O3N468.7468.804.204.1614.5814.49
4a-5p-OHC6H423971C22H16O3N468.7468.654.204.1814.5814.50
4a-6o-ClC6H424170C22H15O2N4Cl65.6065.603.753.6813.9114.00
4a-7p-ClC6H423572C22H15ON4Cl65.6065.583.753.8113.9113.86
4a-8p-OH,m-OCH3-C6H324378C23H18O4N466.6666.704.384.4013.5213.60
4b-1p-OCH3C6H419886C23H18O2N472.2472.304.744.8114.6514.72
4b-2o-NO2C6H417581C22H15O3N566.4966.403.803.7517.6217.70
4b-33,4,5(OCH3)3-C6H220378C25H22O4N467.8667.705.015.1112.6612.73
4b-4o-OHC6H421868C22H16O2N471.7371.624.384.2915.2115.30
4b-5p-OHC6H422162C22H16O2N471.7371.664.384.3015.2115.16
4b-6o-ClC6H421672C22H15ON4Cl68.3168.403.913.8314.4814.53
4b-7p-ClC6H423572C22H15ON4Cl68.3168.393.914.0014.4814.51
4b-8p-OH,m-OCH3-C6H323581C23H18O3N469.3469.284.554.4914.0614.10
4c-1p-OCH3C6H424686C22H15O2N4Cl65.6064.303.753.8113.9113.84
4c-2o-NO2C6H419882C21H12O3N5Cl60.3760.452.892.8116.7616.68
4c-33,4,5(OCH3)3-C6H226179C24H24O4N4Cl62.2762.324.144.2112.1012.05
4c-4o-OHC6H423271C21H13O2N4Cl64.8764.913.373.4214.4114.35
4c-5p-OHC6H422269C21H13O2N4Cl64.8765.003.373.4014.4114.50
4c-6o-ClC6H424865C21H12ON4Cl261.9361.852.973.0513.7613.81
4c-7p-ClC6H424280C21H12ON4Cl261.9361.862.973.1013.7613.82
4c-8p-OH,m-OCH3-C6H324365C22H15O3N4Cl63.0963.133.613.5313.3813.31
4d-1p-OCH3C6H424686C21H15O2N4Br59.0859.103.383.4212.5312.60
4d-2o-NO2C6H419882C21H12O3N5Br54.5654.502.622.5615.1515.10
4d-33,4,5(OCH3)-C6H226179C24H19O4N4Br56.8256.893.773.6811.0411.12
4d-4o-OHC6H423271C21H13O2N4Br58.2258.163.023.1112.9312.84
4d-5p-OHC6H422269C21H13O2N4Br58.2258.313.023.1212.9312.86
4d-6o-ClC6H424865C21H12ON4ClBr55.8455.912.682.6112.4012.32
4d-7p-ClC6H421873C21H12ON4ClBr55.8455.802.682.7312.4012.46
4d-8p-OH,m-OCH3C6H322678C23H18O4N4Br57.0457.123.263.2012.0912.11
CHARACTERIZATION DATA OF COMPOUNDS 2, 3 AND 4 The antimicrobial screening of synthesized compounds was carried out by paper disc diffusion method[18] at 100 ppm against Gram +ve bacteria B. substilis, S. aureus and Gram –ve bacteria like E. coli, P. vulgaris. The antifungal activity of the compounds was assayed using fungal species Aspergillus niger and Phytophora. Standard antibacterial streptomycin and antifungal griseofulvin were also screened under similar condition for comparison. (Table 2)
TABLE 2

ANTIMICROBIAL SCREENING DATA OF THE DERIVATIVES OF 4

CompBacteria
Fungi
E. colip. valgarisB. subtilisS. aureusAspergillus nigerPhytophora spp
4a-1171612171715
4a-2571514511
4a-3201419141612
4a-47107481
4a-5145911138
4a-6162017151720
4a-7181817121918
4a-8121511121214
4b-1201911161912
4b-2489748
4b-3252016172016
4b-49414497
4b-55912879
4b-6171116111919
4b-7162016131811
4b-8111214111212
4c-1162013162015
4c-29484810
4c-3201817201820
4c-48612685
4c-5551172316
4c-6221918172316
4c-7192217162417
4c-81111712912
4d-1202011191811
4d-2141468127
4d-3222418252018
4d-47811577
4d-512121491310
4d-6252320162420
4d-7202125202224
4d-8151214111511

Diameter of zone of inhibition in milimeters

ANTIMICROBIAL SCREENING DATA OF THE DERIVATIVES OF 4 Diameter of zone of inhibition in milimeters The result indicated that some compounds exhibit good antimicrobial activity against the above mentioned bacterial and fungal species, while some compounds have moderate antimicrobial activity against both Gram +ve and Gram –ve bacterial and fungal species. It was absovered that introduction of -OCH3 and -Cl groups to the heterocyclic frame work enhanced antibacterial and antifungal activities.
  5 in total

1.  Quinazoline derivatives with antitubercular activity.

Authors:  J Kunes; J Bazant; M Pour; K Waisser; M Slosárek; J Janota
Journal:  Farmaco       Date:  2000 Nov-Dec

2.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

3.  Synthesis and evaluation of some new fluorinated hydroquinazoline derivatives as antifungal agents.

Authors:  M M Ghorab; S M Abdel-Gawad; M S El-Gaby
Journal:  Farmaco       Date:  2000-04

4.  Thromboxane synthetase inhibitors and antihypertensive agents. 4. N-[(1H-imidazol-1-yl)alkyl] derivatives of quinazoline-2,4(1H,3H)-diones, quinazolin-4(3H)-ones, and 1,2,3-benzotriazin-4(3H)-ones.

Authors:  W B Wright; A S Tomcufcik; P S Chan; J W Marsico; J B Press
Journal:  J Med Chem       Date:  1987-12       Impact factor: 7.446

5.  Design and synthesis of some new derivatives of 3H-quinazolin-4-one with promising anticonvulsant activity.

Authors:  Abdel Ghany Aly El-Helby; Mohammed Hemeda Abdel Wahab
Journal:  Acta Pharm       Date:  2003-06       Impact factor: 2.230

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.